A home health enrollment freeze that could shrink the provider pool, a hospice industry calling for quality transparency it doesn't yet have, a new pre-claim review finding with real implications for home health access, and a push to make dementia care less reliant on medication — this week's caregiving news, read for families.

What changed for caregivers this week — June 29, 2026

A home health enrollment freeze with no clear end date, a hospice industry acknowledging it has a trust problem, a Medicare pre-claim review experiment that worked in one state and almost nowhere else, and a nonprofit pushing harder on nonpharmacological dementia care — a week where the gaps between what the system promises and what families actually encounter kept widening.

The home health enrollment moratorium is likely to stay in place through the midterms — and the provider pool is already shrinking

CMS imposed a moratorium on new home health agency enrollment in several high-fraud markets earlier this year, and reporting this week from Home Health Care News lays out why industry leaders now expect it to remain in place well into 2027. The reasoning is partly political — moratoriums of this kind have historically been extended in the run-up to midterm elections, when CMS is reluctant to be seen relaxing fraud controls — and partly precedent-based, given how long similar moratoriums in hospice markets have persisted once established. The affected markets include parts of Texas, Florida, and other states that have seen the highest concentrations of fraudulent home health billing.

For families in those markets, the moratorium's practical effect is not that fraudulent agencies disappear — it is that legitimate new agencies cannot enter the market to compete, and existing agencies face no new competition for patients or staff. That tends to consolidate referrals among a smaller number of providers and reduce the leverage families have when an agency isn't responsive or isn't a good fit. If a parent is being discharged from a hospital in one of the moratorium markets and the discharge planner offers a short list of home health options, that list may be shorter than it would have been a year ago — and asking whether any of the agencies on it are currently accepting new patients under traditional Medicare (not just Medicare Advantage) is worth doing before discharge day.

Hospice leaders are calling for more quality transparency — which means families currently can't easily compare providers

Executives from Compassus and Providence told Hospice News this week that the hospice industry needs significantly more public quality reporting to rebuild trust eroded by the fraud wave that has dominated coverage of the sector for the past two years. The argument is that legitimate providers are being tarred by association with fraudulent operators, and that better public data — on symptom management outcomes, family satisfaction, and care quality — would allow families and referral sources to distinguish between them. The executives specifically called for more granular reporting than what currently appears on Medicare's Care Compare tool.

The honest implication of that argument is that right now, the data families need to make that distinction is not reliably available. Care Compare lists hospices and shows some quality measures, but the measures are limited and the fraud-heavy markets have demonstrated that licensure and Medicare certification are not sufficient filters. Until more robust reporting exists, the questions that matter most have to be asked directly: How long has this agency been operating under its current ownership? What is the average length of enrollment for patients before death — and what share of patients are discharged alive? What does the on-call coverage look like on nights and weekends, and who specifically answers when a family calls at 2 a.m.? A hospice that can answer those questions with specifics is operating differently than one that responds with brochure language.

A Medicare pre-claim review experiment cut $1.2 billion in Illinois — and barely moved the needle anywhere else

New research on CMS's pre-claim review demonstration, covered this week by Home Health Care News, found that the program — which requires home health agencies to submit documentation for review before Medicare pays a claim — produced dramatic results in Illinois, where it reduced improper payments by $1.2 billion, but had little measurable effect in the other states where it was tested. Researchers attribute the Illinois result to the state's specific fraud environment and the way the review process was implemented there. The finding matters for policy because CMS is weighing whether to expand pre-claim review more broadly as a fraud-control tool.

For families, the relevance is indirect but real. Pre-claim review, when it functions as designed, slows down the payment cycle for home health agencies — which means agencies in states where it gets expanded may tighten their admission criteria further for patients whose authorizations are likely to face scrutiny. The families most affected are those whose parent or spouse has a complex or borderline eligibility profile: someone who needs skilled nursing visits but whose documentation of homebound status is thin, or someone whose plan of care requires justification that a busy agency may not prioritize. If a home health referral stalls after a hospitalization and the explanation is vague, asking specifically whether a pre-claim review request has been submitted — and what its status is — gives the family a concrete thread to pull.

The I'm Still Here Foundation is pushing nonpharmacological dementia programming into more communities — and the bar for what "good" looks like is rising

The I'm Still Here Foundation, profiled this week by Senior Housing News, has spent years bringing structured engagement programming to memory care communities — specifically the Timeslips creative storytelling method and other approaches designed to meet people with dementia where their abilities actually are, rather than where they used to be. The foundation's work is focused on reducing the behavioral symptoms — agitation, withdrawal, distress — that are most often managed with antipsychotic medications, by addressing the boredom, disorientation, and lack of purposeful activity that drive those symptoms in the first place.

The foundation's reach is still limited relative to the number of memory care communities operating nationally, but its work is part of a broader shift — visible also in Benchmark Senior Living's programming overhaul reported two weeks ago — toward holding memory care operators to a higher standard on engagement and medication use. For families currently evaluating memory care communities, or whose parent is already in one and showing signs of increased agitation or sedation, the question worth pressing is what structured programming runs on evenings and weekends, not just during weekday activity hours. Behavioral symptoms in dementia tend to peak in late afternoon and evening. A community whose answer to that question is specific — named activities, named staff, a described approach — is making different choices than one whose answer is a general assurance that residents are well cared for.

The Caregiving Newsroom is published weekly on Monday morning. If a story below should have been on this list, or one shouldn't have been, reply to this post by email — we read everything.